Peter B Berger, MD
April 15th, 2011
Harnessing the Power of the EMR for Clinical Research Recruiting
Peter B Berger, MD
The days of passively recruiting for outpatient clinical trials by having a research coordinator in a clinic manually review charts to determine which patients are eligible will soon be over. How soon is hard to tell, but institutions like Geisinger Medical Center in Pennsylvania, where I am Director of the Center for Clinical Studies (and […]
August 9th, 2010
The GP IIb/IIIa Inhibitor Wars: Not Ready To Surrender
Richard A. Lange, MD, MBA and Peter B Berger, MD
Although two recent studies (EVA-MI and SCAAR) report that eptifibatide is as effective as abciximab with respect to myocardial reperfusion and clinical events in patients undergoing primary PCI, the thoughtful and balanced editorial accompanying them points out that the studies “ought not be considered convincing or as level 1 evidence” that the GP IIb/IIIa inhibitors […]
NEJM Journal Watch — Recent Cardiology Articles- 10-Year Mortality in Patients Undergoing PCI for First-Time ST-Segment Elevation Myocardial Infarction
- Possible Connection Between Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
- Does Knowledge of Asymptomatic Coronary Ischemia Improve Outcomes After Major Vascular Surgery?
- Effect of Telecardiology After Hospital Discharge for Acute Coronary Syndromes
- Intensive BP Reduction for Preventing Major Adverse Cardiovascular Events